Eligibility NCT00079482 AML
Study of CEP-701 in Patients With Acute Myeloid Leukemia (AML) See http://clinicaltrials.gov/ct2/show/study/NCT00079482

Eligibility AML NCT00079482

  1. StudyEvent: Eligibility
    1. Eligibility AML NCT00079482
Name
Type
Description | Question | Decode (Coded Value)
Data type
Alias
Item Group
Einschlusskriterien
C1512693 (UMLS CUI-1)
AML
Item
boolean
C0023467 (UMLS CUI-1)
Relapse
Item
boolean
C0277556 (UMLS CUI-1)
FLT3 mutation
Item
boolean
C2348501 (UMLS CUI-1)
Age
Item
boolean
C0001779 (UMLS CUI-1)
Life expectancy
Item
boolean
C0023671 (UMLS CUI-1)
ECOG
Item
boolean
C1828127 (UMLS CUI-1)
Not pregnant nor lactating
Item
boolean
C0232973 (UMLS CUI-1)
C1518422 (UMLS CUI-2)
C0006147 (UMLS CUI-3)
Item Group
Ausschlusskriterien
C0680251 (UMLS CUI-1)
Bilirubin
Item
boolean
C0201913 (UMLS CUI-1)
ALT and AST
Item
boolean
C0001899 (UMLS CUI-1)
C0004002 (UMLS CUI-2)
Serum creatinine
Item
boolean
C0201976 (UMLS CUI-1)
Ejection fraction (EF)
Item
boolean
C0232174 (UMLS CUI-1)
Infection
Item
boolean
C0021311 (UMLS CUI-1)
Major physical or psychiatric condition
Item
boolean
CNS involvement
Item
boolean
C0449389 (UMLS CUI-1)
FLT3 inhibitor treatment
Item
boolean
C0013227 (UMLS CUI-1)
CL414898 (UMLS CUI-2)
C1333568 (UMLS CUI-3)
HIV treatment
Item
boolean
C0019693 (UMLS CUI-1)
Gastrointestinal ulceration or bleeding
Item
boolean
C0237938 (UMLS CUI-1)
C0017181 (UMLS CUI-2)
Other investigational drug
Item
boolean
C1516879 (UMLS CUI-1)